As the FTC continues to crack down on pharmaceutical manufacturers’ allegedly improper listing of patents in the FDA Orange ...

Aigen Investment Management LP purchased a new stake in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Free Report) in the 3rd quarter, according to its most recent filing with the SEC. The institutional ...

Amneal Pharmaceuticals (NASDAQ:AMRX – Free Report) had its price target increased by Piper Sandler from $9.00 to $11.00 in a ...

Sandoz Inc., Pfizer Inc., and Amneal Pharmaceuticals Inc. are among a group of generic-drug manufacturers that will face some ...

Have you been paying attention to shares of Amneal Pharmaceuticals (AMRX)? Shares have been on the move with the stock up 6.2% over the past month. The stock hit a new 52-week high of $9.32 in the ...

Amneal Pharmaceuticals (NYSE:NASDAQ:AMRX), a prominent player in the generic pharmaceuticals industry, has been garnering attention from analysts due to its recent strong performance and strategic ...

Have you been paying attention to shares of Amneal Pharmaceuticals (AMRX)? Shares have been on the move with the stock up 6.2% over the past month. The stock hit a new 52-week high of $9.32 in the ...

Amneal Pharmaceuticals (NYSE:NASDAQ:AMRX), a prominent player in the generic pharmaceuticals industry, has been garnering attention from analysts due to its recent strong performance and strategic ...

On Monday, Amneal Pharmaceuticals Inc (AMRX) stock saw a modest uptick, ending the day at $9.2 which represents a slight increase of $0.47 or 5.38% from the prior close of $8.73. The stock opened at ...